Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
      Azathioprine*/administration & dosage ; Azathioprine*/therapeutic use ; Kidney Transplantation*/adverse effects ; Immunosuppressive Agents*/administration & dosage ; Immunosuppressive Agents*/therapeutic use ; Carcinoma, Squamous Cell*/secondary ; Carcinoma, Squamous Cell*/drug therapy; Humans ; Male ; Aged ; Lymphatic Metastasis ; Lymph Nodes/pathology ; Lymph Nodes/immunology ; Lymph Nodes/drug effects
    • Abstract:
      Introduction: We report the partial regression of metastatic squamous cell carcinoma (SCC) after reduction of long-term azathioprine therapy while awaiting surgery. The patient was a 69-year-old man with a history of kidney transplantation. Moderately differentiated SCC arising in the anterior neck was initially diagnosed, followed later by poorly differentiated SCC metastases to cervical lymph nodes. Lymph node clearance was performed 28 days after a reduction in azathioprine dosage. The palpable lymph node lesion had noticeably decreased in size at the time of surgery, and subsequent histology only detected 7mm and 0.2mm deposits of poorly differentiated SCC in 2 of 5 level I nodes, and a further 10 reactive nodes from levels II and III. One positive level I and another benign level II/III node, demonstrated necrosis, histiocytic infiltration and fibrosis, interpreted as features of regression. Hence, we investigated the role of immune cells in the partial regression of metastatic SCC after reduction of long-term azathioprine therapy while awaiting surgery.
      Methods: Multispectral immunohistochemistry using custom markers was performed on regions of interest of excised cervical lymph nodes, encompassing the entire SCC deposit and the surrounding adjacent stroma to quantify to number and types of immune cells present.
      Results: Multispectral immunohistochemistry revealed the heavy infiltration of activated T cells in the tumour, as well as PD-L1+ antigen-presenting cells in the surrounding adjacent stroma, suggesting an immunologically mediated partial regression.
      Discussion: We hypothesize that this reaction was triggered by azathioprine dose reduction. Dose modification of long-term immunosuppressive medications in patients with a transplantation history who later develop SCCs warrants further investigation.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
      (Copyright © 2024 Ormston, Da Gama Duarte, Quigley, Jackett, Whitlam, Behren and Gyorki.)
    • References:
      Gastroenterol Hepatol (N Y). 2006 Jan;2(1):58-63. (PMID: 28210198)
      Int J Mol Sci. 2020 Apr 22;21(8):. (PMID: 32331425)
      Science. 2006 Sep 29;313(5795):1960-4. (PMID: 17008531)
      Am J Transplant. 2016 Dec;16(12):3490-3503. (PMID: 27163483)
      Am J Transplant. 2010 Aug;10(8):1889-96. (PMID: 20659094)
      Immunity. 2021 Sep 14;54(9):2117-2132.e7. (PMID: 34525340)
      Am J Transplant. 2016 Feb;16(2):565-73. (PMID: 26824445)
      Anticancer Drugs. 2017 Sep;28(8):819-830. (PMID: 28609309)
      J Immunother Cancer. 2021 Jan;9(1):. (PMID: 33479027)
      Front Oncol. 2018 Jan 23;8:3. (PMID: 29410946)
      Am J Otolaryngol. 2017 May - Jun;38(3):325-328. (PMID: 28202188)
      Clin Cancer Res. 2024 Jan 5;30(1):224-234. (PMID: 37874322)
      Am J Transplant. 2018 Dec;18(12):2977-2986. (PMID: 29802791)
      Annu Rev Immunol. 2024 Jun;42(1):317-345. (PMID: 38941605)
      J Immunother Cancer. 2021 Nov;9(11):. (PMID: 34782426)
      Immunity. 2024 Aug 13;57(8):1734-1751. (PMID: 39142275)
      JAAD Case Rep. 2024 Jan 28;45:106-109. (PMID: 38434599)
      Otolaryngol Head Neck Surg. 2019 Mar;160(3):439-446. (PMID: 30348055)
    • Contributed Indexing:
      Keywords: case report; cutaneous squamous cell carcinoma; immunosuppression; kidney transplant; metastatic squamous cell carcinoma
    • Accession Number:
      MRK240IY2L (Azathioprine)
      0 (Immunosuppressive Agents)
    • Publication Date:
      Date Created: 20241115 Date Completed: 20241115 Latest Revision: 20241116
    • Publication Date:
      20241116
    • Accession Number:
      PMC11561406
    • Accession Number:
      10.3389/fimmu.2024.1474663
    • Accession Number:
      39544941